LianBio

LIANY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$2,476$311,137-$110,159-$196,561
Dep. & Amort.$801$1,327$1,005$526
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$19,148$8,664
Change in WC$469-$23,326$7,986$13,803
Other Non-Cash$0-$30,203-$17,046$9,397
Operating Cash Flow$3,747$258,936-$99,067-$164,171
Investing Activities
PP&E Inv.$0-$375-$1,843-$948
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$148,492-$302,776-$155,196
Inv. Sales/Matur.$128,855$248,175$235,500$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$128,855$99,309-$69,119-$156,144
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$1,782$1,708$311,083
Stock Repurch.$0$0$0$0
Dividends Paid-$550,697$0$0$0
Other Fin. Act.$0$0$0$2,606
Financing Cash Flow-$550,697$1,782$1,708$313,689
Forex Effect$31,213-$664$17,522-$19,547
Net Chg. in Cash-$386,882$359,363-$148,956-$26,173
Supplemental Information
Beg. Cash$438,584$79,221$228,177$254,350
End Cash$51,702$438,584$79,221$228,177
Free Cash Flow$3,747$258,561-$100,910-$165,119